Brief: Spyre Therapeutics Inc - Suspends And Terminates ATM Prospectus For At-The-Market Offering Effective April 13, 2026 - SEC Filing
13/04/2026 22:06
April 13 (Reuters) - Spyre Therapeutics Inc SYRE.O: SPYRE THERAPEUTICS INC - SUSPENDS AND TERMINATES ATM PROSPECTUS FOR AT-THE-MARKET OFFERING EFFECTIVE APRIL 13, 2026 - SEC FILING Source text: [] Further company coverage: SYRE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock